Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
10.18
+0.09 (0.89%)
Nov 20, 2024, 4:00 PM EST - Market closed
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $1.19 billion as of November 21, 2024. Its market cap has increased by 439.50% in one year.
Market Cap
1.19B
Enterprise Value
1.07B
1-Year Change
439.50%
Ranking
Category
Stock Price
$10.18
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $1.19B, an increase of 52.36%. That is a compound annual growth rate of 9.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.18B | 287.39% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | 1.23B | 56.71% |
| Jan 31, 2020 | 782.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rocket Pharmaceuticals | 1.20B |
| Innoviva | 1.20B |
| Mesoblast | 1.19B |
| Tilray Brands | 1.18B |
| CareDx | 1.18B |
| Maravai LifeSciences Holdings | 1.17B |
| Aurinia Pharmaceuticals | 1.16B |
| Progyny | 1.16B |